Hanauske AR - Search Results

1

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.

Hanauske AR, Osborne CK, Chamness GC, Clark GM, Forseth BJ, Buchok JB, Arteaga CL, Von Hoff DD. Hanauske AR, et al. Eur J Cancer Clin Oncol. 1987 May;23(5):545-51. doi: 10.1016/0277-5379(87)90318-x. Eur J Cancer Clin Oncol. 1987. PMID: 3498632

2

A new in vitro screening system for anticancer drugs for the treatment of non-small cell lung cancer.

Hanauske U, Hanauske AR, Clark GM, Tsen D, Buchok J, von Hoff DD. Hanauske U, et al. Among authors: hanauske ar. Sel Cancer Ther. 1989;5(3):97-111. doi: 10.1089/sct.1989.5.97. Sel Cancer Ther. 1989. PMID: 2554453

3

Determination of transforming growth factor activity in effusions from cancer patients.

Hanauske AR, Arteaga CL, Clark GM, Buchok J, Marshall M, Hazarika P, Pardue RL, Von Hoff DD. Hanauske AR, et al. Cancer. 1988 May 1;61(9):1832-7. doi: 10.1002/1097-0142(19880501)61:9<1832::aid-cncr2820610919>3.0.co;2-j. Cancer. 1988. PMID: 3162700

4

Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.

Arteaga CL, Hanauske AR, Clark GM, Osborne CK, Hazarika P, Pardue RL, Tio F, Von Hoff DD. Arteaga CL, et al. Among authors: hanauske ar. Cancer Res. 1988 Sep 1;48(17):5023-8. Cancer Res. 1988. PMID: 3165707

5

Recent improvements in the human tumor cloning assay for sensitivity testing of antineoplastic agents.

Hanauske AR, Hanauske U, von Hoff DD. Hanauske AR, et al. Among authors: hanauske u. Eur J Cancer Clin Oncol. 1987 Jun;23(6):603-5. doi: 10.1016/0277-5379(87)90253-7. Eur J Cancer Clin Oncol. 1987. PMID: 3653184 No abstract available.

6

Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units.

Raymond E, Hanauske A, Faivre S, Izbicka E, Clark G, Rowinsky EK, Von Hoff DD. Raymond E, et al. Anticancer Drugs. 1997 Apr;8(4):379-85. doi: 10.1097/00001813-199704000-00011. Anticancer Drugs. 1997. PMID: 9180392

7

Recombinant human transforming growth factor-alpha stimulates in vitro colony formation of fresh human tumor specimens.

Hanauske AR, Hanauske U, Buchok J, Von Hoff DD. Hanauske AR, et al. Among authors: hanauske u. Int J Cell Cloning. 1988 May;6(3):221-9. doi: 10.1002/stem.5530060307. Int J Cell Cloning. 1988. PMID: 3165110 Free article.

8

Assessment of biological activity of linear alpha-transforming growth factor and monospecific antibodies to alpha-transforming growth factor and linear alpha-transforming growth factor.

Hanauske AR, Buchok JB, Pardue RL, Muggia VA, Von Hoff DD. Hanauske AR, et al. Cancer Res. 1986 Nov;46(11):5567-70. Cancer Res. 1986. PMID: 3463415

9

Human colon cancer cell lines secrete alpha TGF-like activity.

Hanauske AR, Buchok J, Scheithauer W, Von Hoff DD. Hanauske AR, et al. Br J Cancer. 1987 Jan;55(1):57-9. doi: 10.1038/bjc.1987.12. Br J Cancer. 1987. PMID: 3493023 Free PMC article. No abstract available.

10

Phase I clinical trial of carbetimer.

Hanauske AR, Melink TJ, Harman GS, Clark GM, Craig JB, Koeller JM, Boldt DH, Kantor B, Kisner DL, Orczyk G, et al. Hanauske AR, et al. Cancer Res. 1988 Sep 15;48(18):5353-7. Cancer Res. 1988. PMID: 2842047

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters